Anti-obesity Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Anti-obesity Drugs Market
The anti-obesity drugs market size was valued at USD 4.51 billion in 2023, and the market is now projected to grow from USD 6.15 billion in 2024 to USD 37.94 billion by 2032, exhibiting a CAGR of 25.5% during the forecast period of 2024-2032.
Pandemic slowed anti-obesity drugs market growth. In 2020, the growth ended up impeded via fewer in-person visits to healthcare specialists and the closure of non-critical services. In 2021, telemedicine and online pharmacies reduced the terrible impact on the market with the useful resource of converting in-man or woman health facility visits with repeat prescriptions. Following the pandemic, the enterprise grew due to easier COVID-19 regulations and growing weight problems charges globally. The market is anticipated to develop drastically because of new product releases and robust pipelines from key players.
Obesity has end up a international epidemic, causing as a minimum 2.8 Mil deaths every year, in step with WHO figures. As obesity costs rise, there could be a more need for effective treatment alternatives to address the contamination. As weight problems will become greater commonplace in the destiny, there will be a developing need for novel anti-weight problems remedies in the worldwide market. To meet the need for anti-obesity medicinal drugs, main and developing agencies have released R&D activities.
Obesity has end up an epidemic because of its widespread upward push in occurrence over latest a long time. Obesity is a primary public fitness challenge because it raises the hazard of continual ailments such kind 2 diabetes, cardiovascular ailment, high blood stress, and cancer. This has multiplied public know-how of excessive chronic contamination prevention through appropriate motion plans.
Comprehensive Analysis of Anti-obesity Drugs Market
The global anti-obesity drugs market is classified into prescribed drugs and over-the-counter pills. Prescription drugs dominate the marketplace because of key players investing in R&D and strategic partnerships. Healthcare professionals' prescriptions additionally raise income. The marketplace is split into clinic pharmacy, retail, and online pharmacy. Retail and online pharmacy are predicted to generate the best revenue in 2023 due to increased usage of e-pharmacies platforms and the provision of anti-obesity capsules. Obesity is a persistent circumstance, and sufferers need refills for lengthy-term treatment, leading to more adoption of anti-obesity drugs thru these channels.
The North America region lead the anti-obesity drugs market share by benefitting a market size of USD 1.91 billion in 2023 due to rapid expansion can be linked to high obesity rates in high-income nations with high healthcare costs per person. According to 2021 research released by the National Library of Medicine, people with obesity in the United States incur high yearly medical care expenses of USD 2,505. These costs rise dramatically with obesity class, from 68.4% for sophistication 1 to 233.6% for class three.
The market is concentrated, with some key organizations controlling a sizeable part of it. Novo Nordisk A/S is a market chief with a robust product variety and recent regulatory approvals that improve increase. In June 2021, Novo Nordisk A/S had been given FDA clearance for Wegovy, a treatment for persistent weight manipulates in humans with weight problems or obese and at the least one weight-related comorbidity. The commercial corporation expects advanced income of Wegovy, an obesity drug, in 2024 in comparison to 2023.
In November 2023, Lilly reported that Zepbound has been approved by the United States Food and Drug Administration to manage persistent weight in obese individuals.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 25.5% from 2024 to 2032
Unit Value (USD billion)
Segmentation
By Type
Prescription Drugs
OTC Drugs
By Distribution Channel
Hospital Pharmacy
Retail and Online Pharmacy
By Geography
North America (By Type, By Distribution Channel, By Country)
U.S.
Canada
Europe (By Type, By Distribution Channel, By Country/Sub-Region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Type, By Distribution Channel, By Country/Sub-Region)
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Type, By Distribution Channel, By Country/Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Type, By Distribution Channel, By Country/Sub-Region)
GCC
South Africa
Rest of Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Obesity - By Key Countries/Region
- 4.2. New Product Launches
- 4.3. Key Industry Developments – Mergers, Acquisition, and Partnerships
- 4.4. Pipeline Analysis
- 4.5. Impact of COVID-19 on the Global Market
- 5. Global Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Type
- 5.1.1. Prescription Drugs
- 5.1.2. OTC Drug
- 5.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.2.1. Hospital Pharmacy
- 5.2.2. Retail and Online Pharmacy
- 5.3. Market Analysis, Insights and Forecast – By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East & Africa
- 6. North America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Type
- 6.1.1. Prescription Drugs
- 6.1.2. OTC Drug
- 6.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.2.1. Hospital Pharmacy
- 6.2.2. Retail and Online Pharmacy
- 6.3. Market Analysis, Insights and Forecast – By Country
- 6.3.1. U.S.
- 6.3.2. Canada
- 7. Europe Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Type
- 7.1.1. Prescription Drugs
- 7.1.2. OTC Drug
- 7.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.2.1. Hospital Pharmacy
- 7.2.2. Retail and Online Pharmacy
- 7.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.3.1. Germany
- 7.3.2. U.K.
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Scandinavia
- 7.3.7. Rest of Europe
- 8. Asia Pacific Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Type
- 8.1.1. Prescription Drugs
- 8.1.2. OTC Drug
- 8.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.2.1. Hospital Pharmacy
- 8.2.2. Retail and Online Pharmacy
- 8.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.3.1. India
- 8.3.2. China
- 8.3.3. Japan
- 8.3.4. Australia
- 8.3.5. Southeast Asia
- 8.3.6. Rest of Asia Pacific
- 9. Latin America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Type
- 9.1.1. Prescription Drugs
- 9.1.2. OTC Drug
- 9.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.2.1. Hospital Pharmacy
- 9.2.2. Retail and Online Pharmacy
- 9.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 9.3.1. Brazil
- 9.3.2. Mexico
- 9.3.3. Rest of Latin America
- 10. Middle East & Africa Anti-obesity Drugs Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Type
- 10.1.1. Prescription Drugs
- 10.1.2. OTC Drug
- 10.2. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.2.1. Hospital Pharmacy
- 10.2.2. Retail and Online Pharmacy
- 10.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 10.3.1. GCC
- 10.3.2. South Africa
- 10.3.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Novo Nordisk A/S
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. GlaxoSmithKline
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Vivus Pharmaceuticals
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Currax Pharmaceuticals LLC
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. F. Hoffmann-La Roche Ltd
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Pfizer Inc.
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Sandoz International GmbH (Novartis AG)
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Boehringer Ingelheim International GmbH
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook